Chwilio Deddfwriaeth

Chwiliad Uwch

Council Regulation (EEC) No 2377/90 (repealed)Dangos y teitl llawn

Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)

Help about what version

Pa Fersiwn

Help about advanced features

Nodweddion Uwch

Rhagor o Adnoddau

PDF o Fersiynau Diwygiedig

Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Status:

Point in time view as at 12/02/2007.

Changes to legislation:

There are currently no known outstanding effects for the Council Regulation (EEC) No 2377/90 (repealed), Division 2. . Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

[F12. Antiparasitic agents U.K.

2.1. Agents acting against endoparasites U.K.

2.1.1. Salicylanilides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Closantel Closantel Bovine 1 000  μg/kg Muscle
3 000  μg/kg Fat
1 000  μg/kg Liver
3 000  μg/kg Kidney
Ovine 1 500  μg/kg Muscle
2 000  μg/kg Fat
1 500  μg/kg Liver
5 000  μg/kg Kidney
[F2Rafoxanide Rafoxanide Bovine 30 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
30 μg/kg Fat
10 μg/kg Liver
40 μg/kg Kidney
Ovine 100 μg/kg Muscle
250 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney]

Textual Amendments

2.1.2. Tatra-hydro-imidazoles (imidazolthiazoles) U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Levamisole Levamisole Bovine, ovine, porcine, poultry 10 μg/kg Muscle
10 μg/kg Fat
100 μg/kg Liver
10 μg/kg Kidney
2.1.3. Benzimidazoles and pro-benzimidazoles U.K.
a

[F3Not for use in animals producing milk for human consumption.]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F4Albendazole Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole All ruminants 100  μg/kg Muscle
100  μg/kg Fat
1 000  μg/kg Liver
500  μg/kg Kidney
100  μg/kg Milk]
[F5Albendazole oxide Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
1 000  μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk ]
[F4Febantel Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50  μg/kg Muscle
50  μg/kg Fat
500  μg/kg Liver
50  μg/kg Kidney
10  μg/kg Milk
Fenbendazole Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50  μg/kg Muscle
50  μg/kg Fat
500  μg/kg Liver
50  μg/kg Kidney
10  μg/kg Milk]
[F6Flubendazole Sum of flubendazole and (2-amino 1H-benzimidazol-5-yl) (4fluorophenyl) methanone Poultry, porcine 50  μg/kg Muscle
50  μg/kg Skin + fat
400  μg/kg Liver
300  μg/kg Kidney
Flubendazole Flubendazole Poultry 400  μg/kg Eggs ]
[F7Mebendazole Sum of mebendazole methyl (5-(1-hydroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents Ovine, caprine, equidae 60 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
60 μg/kg Fat
400 μg/kg Liver
60 μg/kg Kidney]
[F8Netobimin Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole [X1Bovine, ovine] 100 μg/kg Muscle For oral use only
100 μg/kg Fat
1 000  μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk]
[F4Oxfendazole Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50  μg/kg Muscle
50  μg/kg Fat
500  μg/kg Liver
50  μg/kg Kidney
10  μg/kg Milk]
Oxibendazole Oxibendazole Porcine 100 μg/kg Muscle
500 μg/kg Skin and fat
200 μg/kg Liver
100 μg/kg Kidney
[F4Thiabendazole Sum of thiabendazole and 5-hydroxythiabendazole Caprine 100  μg/kg Muscle
100  μg/kg Fat
100  μg/kg Liver
100  μg/kg Kidney
100  μg/kg Milk]
[F9Triclabendazole Sum of extractable residues that may be oxidised to ketotriclabendazole All ruminants a 225  μg/kg Muscle
100  μg/kg Fat
250  μg/kg Liver
150  μg/kg Kidney]

Editorial Information

Textual Amendments

[F102.1.4. Phenol derivatives including salicylanides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Nitroxinil Nitroxinil Bovine, ovine 400 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
400 μg/kg Kidney
[F4Oxyclozanide Oxyclozanide All ruminants 20  μg/kg Muscle
20  μg/kg Fat
500  μg/kg Liver
100  μg/kg Kidney
10  μg/kg Milk] ]

Textual Amendments

[F112.1.5. Benzenesulphonamides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clorsulon Clorsulon Bovine 35 μg/kg Muscle
100 μg/kg Liver
200 μg/kg Kidney ]

Textual Amendments

[F122.1.6. Piperazine derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Piperazine Piperazine Porcine 400 μg/kg Muscle
800 μg/kg Skind and fat
2 000  μg/kg Liver
1 000  μg/kg Kidney
Chicken 2 000  μg/kg Eggs ]

Textual Amendments

[F132.1.7. Tetrahydropyrimides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Morantel Sum of residues which may be hydrolysed to N-methyl-1,3- propanediamine and expressed as morantel equivalents Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
800 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk
[F14All ruminants 100 μg/kg Muscle
100 μg/kg Fat
800 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk ] ]

Textual Amendments

Textual Amendments

2.2. Agents acting against ectoparasites U.K.

2.2.1. Organophosphates U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F2Coumafos Coumafos Bees 100 μg/kg Honey ]
Diazinon Diazinon Bovine, ovine, caprine 20 μg/kg Milk
Bovine, porcine, ovine, caprine 20 μg/kg Muscle
700 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
[F8Phoxim Phoxim Ovine 50 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
400 μg/kg Fat
50 μg/kg Kidney
Porcine 20 μg/kg Muscle
700 μg/kg Skin and fat
20 μg/kg Liver
20 μg/kg Kidney
[F15Chicken 25  μg/kg Muscle
550  μg/kg Skin + fat
50  μg/kg Liver
30  μg/kg Kidney
60  μg/kg Eggs ] ]

Textual Amendments

2.2.2. Formamidines U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Amitraz Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz Bovine 200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
Ovine 400 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
Porcine 400 μg/kg Skin and fat
200 μg/kg Liver
200 μg/kg Kidney
[F5 Bees (honey) 200 μg/kg Honey ]
[F16 Caprine 200  μg/kg Fat
100  μg/kg Liver
200  μg/kg Kidney
10  μg/kg Milk ]

Textual Amendments

2.2.3. Pyrethroids U.K.
a

[F17Further provisions in Commission Directive 98/82/EC are to be observed ( OJ L 290, 29.10.1998, p. 25 ).]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F8 [X1Cyhalothrin Cyhalothrin (sum of isomers) Bovine 500 μg/kg Fat Further provisions in Council Directive 94/29/EC are to be observed
50 μg/kg Kidney
50 μg/kg Milk
Cyfluthrin Cyfluthrin (sum of isomers) Bovine 10 μg/kg Muscle
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
20 μg/kg Milk] ]
[F18 [F4Deltamethrin Deltamethrin All ruminants 10  μg/kg Muscle
50  μg/kg Fat
10  μg/kg Liver
10  μg/kg Kidney
20  μg/kg Milk]
[F19Fin fish 10 μg/kg Muscle and skin in natural proportions] ]
[F20Fenvalerate Fenvalerate (sum of RR, SS, RS and SR isomers) Bovine 25 μg/kg Muscle
250 μg/kg Fat
25 μg/kg Liver
25 μg/kg Kidney
40 μg/kg Milk]
Flumethrin Flumethrin (sum of trans-Z isomers) Bovine 10 μg/kg Muscle
150 μg/kg Fat
20 μg/kg Liver
10 μg/kg Kidney
30 μg/kg Milk
[F21 Ovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
150 μg/kg Fat
20 μg/kg Liver
10 μg/kg Kidney ]
[F17Permethrin Permethrin (sum of isomers) Bovine 50 μg/kg Muscle
500 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk a ]
[F22Cypermethrin Cypermethrin (sum of isomers) Salmonidae 50 μg/kg Muscle and skin in natural proportions ]
[F4All ruminants 20  μg/kg Muscle
200  μg/kg Fat
20  μg/kg Liver
20  μg/kg Kidney
20  μg/kg Milk a ]
[F23Alphacypermethrin Cypermethrin (sum of isomers) Bovine, ovine 20 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
20 μg/kg Milk] a

Textual Amendments

[F242.2.4. Acyl urea derivatives U.K.
a

[F25Not for use in animals from which milk is produced for human consumption.] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F26Diflubenzuron Diflubenzuron Salmonidae 1 000  μg/kg Muscle and skin in natural proportions ]
[F25Fluazuron Fluazuron Bovine a 200  μg/kg Muscle
7 000  μg/kg Fat
500  μg/kg Liver
500  μg/kg Kidney]
Teflubenzuron Teflubenzuron Salmonidae 500 μg/kg Muscle and skin in natural proportions

Textual Amendments

Textual Amendments

[F272.2.5. Pyrimidines derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Dicyclanil Sum of dicyclanil and 2, 4, 6-triamino-pyrimidine-5-carbonitrile Ovine 200 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
[F28150 μg/kg] Fat
400 μg/kg Liver
400 μg/kg Kidney]

Textual Amendments

Textual Amendments

[F22.2.6. Triazine derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cyromazine Cyromazine Ovine 300 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney]

2.3. Agents acting against endo- and ectoparasites U.K.

2.3.1. Avermectins U.K.
a

[F29Not for use in animals from which milk is produced for human consumption.]

Phramacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Abamectin Avermectin B1a Bovine 10 μg/kg Fat
20 μg/kg Liver
[F12 Ovine 20 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
50 μg/kg Fat
25 μg/kg Liver
20 μg/kg Kidney ]
[F30Doramectin Doramectin All mammalian food producing species a 40 μg/kg Muscle
150 μg/kg Fat
100 μg/kg Liver
60 μg/kg Kidney]
[F31Emamectin Emamectin B1a Fin fish 100 μg/kg Muscle and skin in natural proportions ]
Eprinomectin Eprinomectin B1a Bovine [F3250 μg/kg] Muscle
[F32250 μg/kg] Fat
[F321 500  μg/kg] Liver
[F32300 μg/kg] Kidney
[F3220 μg/kg] Milk
Ivermectin 22, 23-Dihydro-avermectin B1a Bovine 40 μg/kg Fat
100 μg/kg Liver
Porcine, ovine, equidae 20 μg/kg Fat
15 μg/kg Liver
Deer, including reindeer 20 μg/kg Muscle
100 μg/kg Fat
50 μg/kg Liver
20 μg/kg Kidney
[F33 All mammalian food-producing species a 100 μg/kg Fat
100 μg/kg Liver
30 μg/kg Kidney ]
Moxidectin Moxidectin Bovine, ovine 50 μg/kg Muscle
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney
[F34 Bovine 40 μg/kg Milk ]
[F11 Equidae 50 μg/kg Muscle
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney ]
[F35 Ovine 40 μg/kg Milk ]

Textual Amendments

2.4. Agents acting against protozoa U.K.

2.4.1. Triazinetrione derivative U.K.
a

[F36Not for use in animals from which milk is produced for human consumption.

b

For porcine species this MRL relates to ‘ skin and fat in natural proportions ’ .

c

Not for use in animals from which eggs are produced for human consumption.]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Toltrazuril Toltrazuril sulfone Chicken 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
200 μg/kg Skin and fat
600 μg/kg Liver
400 μg/kg Kidney
Turkey 100 μg/kg Muscle
200 μg/kg Skin and fat
600 μg/kg Liver
400 μg/kg Kidney
[F37 Porcine 100 μg/kg Muscle
150 μg/kg Skin and fat
500 μg/kg Liver
250 μg/kg Kidney ]
[F36 All mammalian food producing species a 100  μg/kg Muscle
150  μg/kg Fat b
500  μg/kg Liver
250  μg/kg Kidney
Poultry c 100  μg/kg Muscle
200  μg/kg Skin + fat
600  μg/kg Liver
400  μg/kg Kidney ]

Textual Amendments

[F372.4.2. Quinazolone derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Halofuginone Halofuginone Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
25 μg/kg Fat
30 μg/kg Liver
30 μg/kg Kidney]
[F192.4.3. Carbanilides U.K.
a

[F38Not for use in ovine from which milk is produced for human consumption.] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Imidocarb Imidocarb Bovine 300 μg/kg Muscle
50 μg/kg Fat
2 000  μg/kg Liver
1 500  μg/kg Kidney
50 μg/kg Milk
[F38Ovine a 300 μg/kg Muscle
50 μg/kg Fat
2 000  μg/kg Liver
1 500  μg/kg Kidney ]

Textual Amendments

[F392.4.4. Ionophores U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F6Lasalocid Lasalocid A Poultry 20  μg/kg Muscle
100  μg/kg Skin + fat
100  μg/kg Liver
50  μg/kg Kidney] ] ]

Textual Amendments

Textual Amendments

Yn ôl i’r brig

Options/Help

Print Options

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.

Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.

Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill